ResearcherStony Brook UniversityActive in the last 2 years
Jianjia Ma
Matched on ORCID iD 0009-0006-3776-3409; OpenAlex author ID A5059846461. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2022: 1 paper · 2023: none · 2024: 1 paper
Papers 2
- Early elevations of RAS protein level and activity are critical for the development of PDAC in the context of inflammation. Co-author DOI 10.1016/j.canlet.2024.216694↗
- Differential Effects of Dietary Macronutrients on the Development of Oncogenic KRAS-Mediated Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers14112723↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yongde Luo · 2 shared papers, 2022–2024 · strength 0.35
- Paper Early elevations of RAS protein level and activity are critical for the development of PDAC in the context of inflammat… DOI 10.1016/j.canlet.2024.216694↗
- Paper Differential Effects of Dietary Macronutrients on the Development of Oncogenic KRAS-Mediated Pancreatic Ductal Adenocar… DOI 10.3390/cancers14112723↗
- Weiqin Lu · 2 shared papers, 2022–2024 · strength 0.35
- Paper Early elevations of RAS protein level and activity are critical for the development of PDAC in the context of inflammat… DOI 10.1016/j.canlet.2024.216694↗
- Paper Differential Effects of Dietary Macronutrients on the Development of Oncogenic KRAS-Mediated Pancreatic Ductal Adenocar… DOI 10.3390/cancers14112723↗
- Craig D. Logsdon · 2 shared papers, 2022–2024 · strength 0.35
- Paper Early elevations of RAS protein level and activity are critical for the development of PDAC in the context of inflammat… DOI 10.1016/j.canlet.2024.216694↗
- Paper Differential Effects of Dietary Macronutrients on the Development of Oncogenic KRAS-Mediated Pancreatic Ductal Adenocar… DOI 10.3390/cancers14112723↗
- Liang Zhu · 1 shared paper, 2022 · strength 0.14
- James L. Abbruzzese · 1 shared paper, 2022 · strength 0.14
- Muyun Liu · 1 shared paper, 2022 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.